CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Xilio Therapeutics granted non-qualified stock options to purchase 107,060 shares to three new employees under its 2022 Inducement Stock Incentive Plan, effective July 1, 2026.

Importance:1/10
Sentiment:
0.00
equity compensationinducement grantsNasdaq Rule 5635employee recruitment
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 6, 2026 8:30 PM

Read Original